| scholarly article | Q13442814 |
| P50 | author | Kunihiro Ichinose | Q56987282 |
| P2093 | author name string | George C Tsokos | |
| Tomohiro Koga | |||
| P2860 | cites work | Systemic lupus erythematosus. | Q53202066 |
| Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition | Q56903863 | ||
| Treatment of murine lupus with monoclonal anti-T cell antibody | Q69863949 | ||
| Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus | Q73086966 | ||
| Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus | Q73587050 | ||
| Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression | Q78025502 | ||
| Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus | Q79609793 | ||
| Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus | Q80725358 | ||
| Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells | Q80800895 | ||
| Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95 | Q81361060 | ||
| CREMα overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity | Q83486678 | ||
| The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus | Q84579960 | ||
| Successful treatment of subacute lupus erythematosus with ustekinumab | Q84772264 | ||
| Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller | Q24324585 | ||
| The biological functions of T helper 17 cell effector cytokines in inflammation | Q24614431 | ||
| Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 | Q24635387 | ||
| Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity | Q26863295 | ||
| Lupus nephritis: the evolving role of novel therapeutics | Q26998390 | ||
| A genome-wide association study identifies IL23R as an inflammatory bowel disease gene | Q28270603 | ||
| Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) | Q28280453 | ||
| The cyclic adenosine 5'-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism | Q28771751 | ||
| Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV | Q28972565 | ||
| Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation | Q29614224 | ||
| Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
| Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation | Q29614840 | ||
| Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus | Q33591655 | ||
| HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. | Q33717763 | ||
| Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity | Q33887202 | ||
| The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity | Q33961011 | ||
| IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells | Q34053939 | ||
| Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus | Q34078675 | ||
| Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice | Q34080154 | ||
| Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice | Q34090173 | ||
| The classification of glomerulonephritis in systemic lupus erythematosus revisited | Q34293066 | ||
| Lupus nephritis: a critical review | Q34299943 | ||
| Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus | Q34361763 | ||
| Clinical associations of serum interleukin-17 in systemic lupus erythematosus | Q34365880 | ||
| Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus | Q34412837 | ||
| Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus. | Q34503070 | ||
| IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 | Q34521302 | ||
| Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus | Q34574768 | ||
| The two TORCs and Akt. | Q34617423 | ||
| Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. | Q34765324 | ||
| Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys | Q34892862 | ||
| IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment | Q35078183 | ||
| KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice. | Q35124586 | ||
| Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus | Q35172134 | ||
| Cutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. | Q35566402 | ||
| cAMP-responsive element modulator (CREM)α protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus | Q35604631 | ||
| T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity | Q35836112 | ||
| Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism | Q35884233 | ||
| American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis | Q36221407 | ||
| Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus | Q36252570 | ||
| Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis | Q36302245 | ||
| cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. | Q36339914 | ||
| Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration | Q36507768 | ||
| Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus | Q36901827 | ||
| Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice | Q36948466 | ||
| The chemokine network in systemic lupus erythematous nephritis | Q36991974 | ||
| PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells | Q37143035 | ||
| Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling | Q37168446 | ||
| cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease | Q37272180 | ||
| The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 | ||
| Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities | Q37408824 | ||
| cAMP responsive element modulator (CREM) α mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells | Q37511786 | ||
| CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance | Q37726675 | ||
| The Th17 immune response in renal inflammation | Q37726972 | ||
| IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus | Q37777456 | ||
| The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism | Q37792556 | ||
| IL-17-producing T cells in lupus nephritis | Q37838092 | ||
| IL-17-producing γδ T cells and innate lymphoid cells | Q38040743 | ||
| Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells | Q38206864 | ||
| The role of T cells in systemic lupus erythematosus: an update | Q38232658 | ||
| Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. | Q40499969 | ||
| Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity | Q41959555 | ||
| Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases. | Q42137258 | ||
| Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB/W F1 female mice | Q43716866 | ||
| Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus | Q45025165 | ||
| Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus | Q47422803 | ||
| Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. | Q50906224 | ||
| Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. | Q52529090 | ||
| P304 | page(s) | 95-99 | |
| P577 | publication date | 2016-04-21 | |
| P1433 | published in | Clinical Immunology | Q15752921 |
| P1476 | title | T cells and IL-17 in lupus nephritis | |
| P478 | volume | 185 |
| Q55163735 | Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus. |
| Q39122679 | B cell contribution of the CD4+ T cell inflammatory phenotypes in systemic lupus erythematosus |
| Q90009309 | B cells control lupus autoimmunity by inhibiting Th17 and promoting Th22 cells |
| Q98735477 | Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus |
| Q90398897 | Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis |
| Q64264430 | FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis |
| Q33801351 | IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE). |
| Q87887570 | IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation |
| Q60044009 | Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients |
| Q36184303 | Increased Serum Levels of IL-17A and IL-23 Are Associated with Decreased Vitamin D3 and Increased Pain in Osteoarthritis. |
| Q91594507 | Machine learning approaches to predict lupus disease activity from gene expression data |
| Q33620555 | Pathways leading to an immunological disease: systemic lupus erythematosus |
| Q42059217 | Regulation of MiR-146a and TRAF6 in the Diagnose of Lupus Nephritis |
| Q93122187 | Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity |
| Q39175811 | T cells and autoimmune kidney disease. |
| Q52724555 | T cells from induced and spontaneous models of SLE recognize a common T cell epitope on β2-glycoprotein I. |
| Q38956350 | T cells in Systemic Lupus Erythematosus |
| Q91802506 | Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases |
| Q64972429 | The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be. |
| Q47281638 | The role of CaMK4 in immune responses |
Search more.